[{"uuid": "9f5c0cc7-bb09-3dcf-bcf8-52dc361761d7", "title": "What Are Analysts Talking About Crinetics Pharmaceuticals (CRNX)?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/analysts-talking-crinetics-pharmaceuticals-crnx-223717181.html", "providerPublishTime": 1738190237, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Cu_HMq_jyOKTkawEjHbcaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0GbhhMMV4fTSS_LruqhLnA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "a0b406da-f949-3ef0-bbd2-e214aaa904a1", "title": "Jefferies Upgrades Crinetics Pharmaceuticals to Buy From Hold, $55 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/jefferies-upgrades-crinetics-pharmaceuticals-buy-121341012.html", "providerPublishTime": 1737548021, "type": "STORY", "relatedTickers": ["CRNX"]}, {"uuid": "140f1d04-cf32-334a-92a6-ece60907c8e1", "title": "Is Crinetics Pharmaceuticals (CRNX) Among Billionaire Joseph Edelman\u2019s Long-Term Stock Picks?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-crnx-among-billionaire-211016606.html", "providerPublishTime": 1737493816, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Cu_HMq_jyOKTkawEjHbcaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0GbhhMMV4fTSS_LruqhLnA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "3b918354-ab7d-3a85-a25c-2aa40ce55239", "title": "Crinetics Pharmaceuticals, Inc. (CRNX): The Biotech Stock with Biggest Upside Potential", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-inc-crnx-biotech-161222963.html", "providerPublishTime": 1737130342, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Cu_HMq_jyOKTkawEjHbcaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0GbhhMMV4fTSS_LruqhLnA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/65df386db36fa7a5d38bc22023059fd6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "5a64b9ad-ef3a-3933-ad90-27f93b095240", "title": "Crinetics Shares Fall After Reporting 'Positive' Phase 2 Results for Congenital Adrenal Hyperplasia Treatment", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/crinetics-shares-fall-reporting-apos-181922701.html", "providerPublishTime": 1736533162, "type": "STORY", "relatedTickers": ["CRNX"]}, {"uuid": "e3cd5cc0-6ee9-30f6-a1cc-bc68e5cc1ea4", "title": "Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-announces-january-2025-221500112.html", "providerPublishTime": 1736547300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C6YwZtvzo__JBt8F.ZtO3g--~B/aD0yNzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 768, "height": 270, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fTp4WgeYgxg7XPJc1_t5wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "e90ac298-cf51-3d40-8b2d-071ecd47d118", "title": "Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/crinetics-announces-positive-topline-results-120000444.html", "providerPublishTime": 1736510400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C6YwZtvzo__JBt8F.ZtO3g--~B/aD0yNzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 768, "height": 270, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fTp4WgeYgxg7XPJc1_t5wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "72c0c96b-d295-3e70-beba-d7f299320cee", "title": "Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-participate-43rd-annual-130000930.html", "providerPublishTime": 1736168400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C6YwZtvzo__JBt8F.ZtO3g--~B/aD0yNzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 768, "height": 270, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fTp4WgeYgxg7XPJc1_t5wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "9131fda1-efad-3253-ab6d-87938f82f61a", "title": "Crinetics Pharmaceuticals Appoints Isabel Kalofonos as\u00a0Chief Commercial Officer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-appoints-isabel-kalofonos-130000091.html", "providerPublishTime": 1734354000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C6YwZtvzo__JBt8F.ZtO3g--~B/aD0yNzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 768, "height": 270, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fTp4WgeYgxg7XPJc1_t5wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "090395b3-dd6a-35fb-9928-4fa6d7ad9eb9", "title": "Crinetics Pharmaceuticals Says US FDA Accepts NDA for Paltusotine to Treat Acromegaly", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-says-us-fda-142125881.html", "providerPublishTime": 1733754085, "type": "STORY", "relatedTickers": ["CRNX"]}, {"uuid": "e79cf66f-5469-3fda-9fb4-9e5132882c17", "title": "Crinetics Pharmaceuticals Inc (CRNX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/crinetics-pharmaceuticals-inc-crnx-q3-071849988.html", "providerPublishTime": 1731482329, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XMsrSLZgzlA1IbCDYyFjpw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/8ed0daa6ef25f4db377b73c8db5e9a83", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BpDC7y_feeM9_ACa8STCnQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/8ed0daa6ef25f4db377b73c8db5e9a83", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}, {"uuid": "964f264e-cf27-3133-8cdd-d9f617082b42", "title": "Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/crinetics-announces-fda-acceptance-drug-130000241.html", "providerPublishTime": 1733749200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C6YwZtvzo__JBt8F.ZtO3g--~B/aD0yNzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 768, "height": 270, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fTp4WgeYgxg7XPJc1_t5wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7629089790345d42d3f8b783f2c3ed55", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRNX"]}]